SCHEMBL1719980

SCHEMBL1719980

O=C(NCc1cccnc1)c1nn2c(C(F)(F)F)cc(-c3ccc(F)cc3)nc2c1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
HPGD P15428 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
MAPK1 P28482 1/20 0.56
MAPT P10636 4/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
GAA P10253 1/20 0.54
KDM4E B2RXH2 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
USP2 O75604 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46
PTGES O14684 1/20 0.45
MCHR1 Q99705 1/20 0.45
POLB P06746 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1719624 0.92 ALDH1A1 (0.58) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL1719199 0.90 ALDH1A1 (0.71) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL1719293 0.87 MAPT (0.65) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL1718105 0.87 ALDH1A1 (0.59) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL1718189 0.87 ALDH1A1 (0.59) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL1718636 0.87 MAPK1 (0.62) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL1719034 0.85 PTGES (0.54) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL1718722 0.85 SMN1; SMN2 (0.49) ALDH1A1NPSR1MAPTGAAKDM4E
SCHEMBL1718102 0.85 KDM4E (0.65) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9
SCHEMBL1718948 0.85 ALDH1A1 (0.64) ALDH1A1HPGDCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP disclosed